Enrollment expected to commence Q3 2025. WASHINGTON, Jan. 28, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused ...
US-based pharmaceutical company 60 Degrees Pharmaceuticals has received approval from the investigational review board (IRB) for a Phase II trial of Arakoda (tafenoquine) for treating chronic ...
60 Degrees Pharmaceuticals, Inc. announced the approval of an Investigational Review Board (IRB) for a Phase II clinical study aimed at evaluating the efficacy and safety of tafenoquine ...
WASHINGTON, Jan. 30, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for infectious ...
Babesiosis is a tick-borne illness caused by babesia parasites. Credit: Yuriy K / Shutterstock. US-based pharmaceutical company 60 Degrees Pharmaceuticals has received approval from the ...
On Tuesday, 60 Degrees Pharmaceuticals Inc (SXTP) stock saw a decline, ending the day at $0.77 which represents a decrease of $-0.10 or -11.49% from the prior close of $0.87. The stock opened at $0.89 ...
On Wednesday morning, the stock of 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP) surged by an impressive 79.03%, reaching a premarket price of $1.38. This surge comes following the announcement that ...
We begin with the political situation in Germany. "The current government, the 'traffic light coalition', has failed," Weber asserts. "We are going to elections half a year before the regular date ...
Cited projections do not guarantee actual salary or job growth. MEd stands for Master of Education and is a master's degree for those working in education. With an MEd, you can advance your teaching ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback